Elizabeth Yeu Lin - 15 Aug 2023 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
15 Aug 2023
Net transactions value
+$159,701
Form type
4
Filing time
17 Aug 2023, 18:02:59 UTC
Previous filing
26 Jun 2023
Next filing
22 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Purchase $159,701 +9,506 +149% $16.80 15,866 15 Aug 2023 By Spouse's Roth IRA
holding TARS Common Stock 12,040 15 Aug 2023 By 401(k) Plan
holding TARS Common Stock 2,000 15 Aug 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.